Lange Jakob, Richard Philipp, Bradley Nick
Ypsomed AG, Burgdorf, Switzerland.
Bergo, Glasgow, United Kingdom.
Med Devices (Auckl). 2014 Jun 12;7:195-203. doi: 10.2147/MDER.S63918. eCollection 2014.
This article presents a late-stage formative usability study of a pen-injector platform device. Such devices are used for the subcutaneous delivery of biopharmaceuticals, primarily for self-administration by the patient. The study was conducted with a broad user population, defined to represent user characteristics across a range of indications. The goals of the study were to confirm that the pen could be used without recurring patterns of use errors leading to hazardous situations, to evaluate the comprehension of the instructions for use (IFU), and to determine if training is necessary. In the study, a total of 36 participants in six groups (health care providers, caregivers, adolescents, diabetics with retinopathy, diabetics with neuropathy, and patients with arthritis) each read the IFU, prepared the device, and performed two simulated injections into an injection pad. Any use errors, near misses, or deviations from the IFU procedure were recorded. The overall success rate (injection completed by the participant without need for assistance) was 94% for the first and 100% for the second injection. Ninety-two percent of the participants reported that they felt confident using the device, 100% found the IFU helpful, and 75% found the device positively comfortable to use. Overall, a total average of 3.35 deviations and errors per user and injection were recorded (there were no near misses). Subtracting the errors without any potential for negative consequences for the injection or the user (trivial deviations), as well as those related to attaching and removing the pen needle (independent of the design of the pen itself), led to an average of 1.31 potentially relevant deviations per user and injection. It was concluded that the pen injector together with the IFU could be safely and efficiently used by all user groups without any training, and thus that the device and IFU in their current form are well suited for use in a range of specific applications.
本文介绍了一种笔式注射器平台设备的后期形成性可用性研究。此类设备用于皮下注射生物制药,主要供患者自行给药。该研究针对广泛的用户群体开展,这些用户代表了一系列适应症的用户特征。研究目的是确认笔式注射器在使用时不会反复出现导致危险情况的使用错误模式,评估对使用说明书(IFU)的理解情况,并确定是否需要培训。在研究中,六组共36名参与者(医疗保健提供者、护理人员、青少年、患有视网膜病变的糖尿病患者、患有神经病变的糖尿病患者和关节炎患者)各自阅读了IFU,准备好设备,并对注射垫进行了两次模拟注射。记录任何使用错误、险些失误或与IFU程序的偏差。第一次注射的总体成功率(参与者无需协助即可完成注射)为94%,第二次注射为100%。92%的参与者表示他们对使用该设备感到自信,100%的人认为IFU有帮助,75%的人认为该设备使用起来非常舒适。总体而言,每位用户每次注射平均记录到3.35次偏差和错误(没有险些失误)。减去对注射或用户没有任何潜在负面影响的错误(轻微偏差)以及与安装和拆卸笔式针头相关的错误(与笔本身的设计无关),每位用户每次注射平均有1.31次潜在相关偏差。得出的结论是,笔式注射器与IFU无需任何培训即可被所有用户组安全有效地使用,因此当前形式的设备和IFU非常适合在一系列特定应用中使用。